• Skip to primary navigation
  • Skip to content
  • Skip to footer
CardioCell

CardioCell

Breakthrough Cardiovascular Technology

  • About Us
    • Overview
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Our Stem Cells
    • Manufacturing
    • Quality Control
    • Exclusive License
  • Clinical Trials
    • Overview
    • Chronic Heart Failure
    • Heart Failure in Patients With Left Ventricular Assist Devices
    • Acute Myocardial Infarction
  • News
    • Press Releases
    • Media Coverage
    • Publications
  • Events
  • LinkedIn

Media Coverage

December 1, 2015

CardioCell Plans Phase IIb Clinical Trial Using Its Stem Cells for Patients With Chronic Heart Failure

News Dec 1, 2015 CardioCell Plans Phase IIb Clinical Trial Using Its Stem Cells for Patients With Chronic Heart Failure CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications, intends to proceed with finalizing a

Read More

Media Coverage,  News

October 21, 2015

CardioCell Board Members and Clinical Trial Leads Collaborate On Peer-Reviewed Paper Published In The Journal Of Cardiovascular Medicine

News Oct 21, 2015 CardioCell Board Members and Clinical Trial Leads Collaborate On Peer-Reviewed Paper Published In The Journal Of Cardiovascular Medicine CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications,

Read More

Media Coverage,  News

May 29, 2015

CardioCell developing stem cell therapy for chronic heart failure

News May 29, 2015 CardioCell developing stem cell therapy for chronic heart failure San Diego biotech startup CardioCell seems to be progressing nicely in developing a stem cell-based therapy for chronic heart failure. READ FULL ARTICLE

Read More

Media Coverage

March 12, 2015

CardioCell adds Stony Brook University to sites conducting phase IIa trial

News Mar 12, 2015 CardioCell adds Stony Brook University to sites conducting phase IIa trial CardioCell, a Stemedica Cell Technologies subsidiary that designs allogeneic stem-cell therapies for cardiovascular indications, has expanded patient recruitment to Stony Brook University’s

Read More

Media Coverage,  News

November 21, 2014

University of Pennsylvania Doses First Patient In Phase IIa Clinical Trial Using CardioCell’s Stem Cell Therapy To Treat Chronic Heart Failure (HF) Due To Non-Ischemic Cardiomyopathy

News Nov 21, 2014 University of Pennsylvania Doses First Patient In Phase IIa Clinical Trial Using CardioCell’s Stem Cell Therapy To Treat Chronic Heart Failure (HF) Due To Non-Ischemic Cardiomyopathy CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that creates

Read More

Media Coverage

September 1, 2014

CardioCell launches trial to assess stem cell therapy for chronic HF

News Sep 1, 2014 CardioCell launches trial to assess stem cell therapy for chronic HF CardioCell announced the initiation of a phase 2a trial of ischemia-tolerant mesenchymal stem cell therapy for patients with chronic HF due to nonischemic cardiomyopathy. READ FULL ARTICLE

Read More

Media Coverage

August 4, 2014

Clinical Trials – Chronic Heart Failure – CardioCell

News Aug 4, 2014 Clinical Trials - Chronic Heart Failure - CardioCell CardioCell began its Phase IIa trial for chronic heart failure patients with non-ischemic cardiomyopathy. FULL ARTICLE APPEARED IN THE AUGUST 2014 PRINT EDITION

Read More

Media Coverage

July 23, 2014

CardioCell Begins Phase IIa Clinical Trial Using itMSC Therapy to Treat Chronic Heart Failure HF Due to Non-Ischemic Cardiomyopathy

News Jul 23, 2014 CardioCell Begins Phase IIa Clinical Trial Using itMSC Therapy to Treat Chronic Heart Failure HF Due to Non-Ischemic Cardiomyopathy CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that creates allogeneic stem-cell therapies for cardiovascular

Read More

Media Coverage

  • « Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Next Page »

Footer

About Us

  • Overview
  • Board of Directors
  • Scientific Advisory Board

Technology

  • Our Stem Cells
  • Manufacturing
  • Quality Control
  • Exclusive License

Clinical Trials

  • Overview
  • Chronic Heart Failure
  • Heart Failure in Patients With Left Ventricular Assist Devices
  • Acute Myocardial Infarction
<section id="bpfwp_contact_card_widget-1" class="widget widget_bpfwp_contact_card_widget"><div class="widget-wrap"><h3 class="widgettitle widget-title">Contact</h3>
info@stemcardiocell.com
</div></section>

Copyright © 2022 · Business Pro Theme on Genesis Framework · WordPress · Log in